Impact of Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction (NAPLES II) – Carlo Briguori
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention (ARMYDA-RECAPTURE) – Germano DiSciascio
Endovascular vs. Open Surgical Repair of Thoracic Aortic Disease (TEVAR) – Davy Cheng
Immediate vs. Next Day Catheterization in Non-ST Elevation Acute Coronary Syndrome (ABOARD) – Gilles Montalescot
The VentrAssist U.S. Pivotal Bridge to Cardiac Transplantation Trial – Andrew J. Boyle
Omega-3 Fatty Acids on Top of Modern Therapy After Acute Myocardial Infarction (OMEGA) – Jochen Senges
Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (REVIVAL-3) – Ilka Ott
Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes (EARLY ACS) – L. Kristin Newby
Dual Treatment Targets for LDL Cholesterol and C-Reactive Protein After Initiation of Rosuvastatin Therapy (JUPITER) – Paul M. Ridker
Continuous Internet Self Reporting vs. Office Monitoring of Blood Pressure for Reducing Cardiovascular Disease Risk – Alfred Bove
Examination of Cardiovascular, Metabolic, and Autonomic Changes Associated with the DASH Diet Alone and in Combination with Exercise and Weight Reduction in Hypertensive Men and Women (ENCORE) – Alan L. Hinderliter
Effect of Rosuvastatin vs. Placebo on Cardiovascular Outcomes in Patients with End-Stage Renal Disease on Hemodialysis (AURORA) – Bengt Fellstrom
Impact of Combinations of Three Blood Pressure Lowering Drugs, a Statin, and Aspirin on Cardiovascular Risk Factors in 2000 Individuals Without Cardiovascular Disease (TIPS) – Salim Yusuf